Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome

Clinical and Experimental Rheumatology

Volumn 16, Issue 6, 1998, Pages 729-732

  Conti, F ^a   Pittoni, V ^a   Sacerdote, P ^b   Priori, R ^a   Meroni, P L ^b   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Beta endorphin; Chronic fatigue syndrome; Neuropeptides

Indexed keywords

BETA ENDORPHIN; NEUROPEPTIDE;

ADOLESCENT; ADULT; AMNESIA; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; SORE THROAT;

ADOLESCENT; ADULT; BETA-ENDORPHIN; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RADIOIMMUNOASSAY;

EID: 0031790106     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. HOLMES GP, KAPLAN JE, GANTZ NM et al.: Chronic fatigue syndrome: A working case definition. Ann Intern Med 1988; 108: 387-9.
2. FUKUDA K, STRAUS SE, HICKIE IH, SHARPE MC, DOBBINS JG, KOMAROFF A: The Chronic Fatigue Syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9.
3. LANDAY AL, JESSOP C, LENNETTE ET, LEVY JA: Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 1991; 338: 707-12.
4. KLONOFF DC: Chronic fatigue syndrome. CID 1992; 15: 812-23.
5. BUCHWALD D, WENER MH, PEARLMAN T, KITH P: Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 1997; 24: 372-3.
6. NATELSON BH, COHEN JM, BRASSLOFF I, LEE HJ: A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurol Sci 1993; 120: 213-7.
7. SCHWARTZ RB, KOMAROFF AL, GARADA BM, et al.: SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am J Roentgenol 1994; 162: 943-51.
8. SACERDOTE P, RUBBOLI F, LOCATELLI L, CICILIATO I, MANTEGAZZA P, PANERAI AE: Pharmacological modulation of neuropeptides in peripheral mononuclear cells. J Neuroimmunol 1991; 32: 35-41.
9. MANFREDI B, SACERDOTE P, BIANCHI M, LOCATELLI L, VELJIC-RADULOVIC J, PANERAI AE: Evidence for an opioid inhibitory tone on T-cell proliferation. J Neuroimmunol 1993; 44: 43-8.
10. PANERAI AE, MANFREDI B, GRANUCCI F, SACERDOTE P: The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine-autocrine effects of the opioid. J Neuroimmunol 1995; 58: 71-6.
11. PANERAI AE, SACERDOTE P: β-endorphin in the immune system: A role at last? Immunology Today 1997; 18: 317-9.
12. BARCELLINI W, SACERDOTE P, BORGHI MO et al.: β-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects. Peptides 1994; 15: 769-75.
13. WIEDERMANN CJ, SACERDOTE P, MUR E et al.: Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with rheumatic diseases. Clin Exp Immunol 1992; 87: 178-82.
14. SACERDOTE P, BREDA M, BARCELLINI W, MERONI PL, PANERAI AE: Age-related changes of beta-endorphin and cholecystokinin in human and rat mononuclear cells. Peptides 1991; 12: 1353-6.
15. LEONE M, SACERDOTE P, D'AMICO D, PANERAI AE, BUSSONE G: Beta-endorphin concentrations in the peripheral blood mononuclear cells of migraine and tension-type headache patients. Cephalalgia 1992; 12: 155-7.
16. RASMUSSEN AK, NIELSEN H, ANDERSEN V et al.: Chronic Fatigue Syndrome - A controlled cross-sectional study. J Rheumatol 1994; 21: 1527-31.
17. MAWLE AC, NISENBAUM R, DOBBINS JG et al.: Seroepidemology of Chronic Fatigue Syndrome: A case-control study. CID 1995; 21: 1386-9.
18. BUCHWALD D, KOMAROFF AL: Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis 1991; 13 (Suppl. 1): S12-18.
19. VON MIKECZ A, KOSTANTINOV K, BUCHWALD DS, GERACE L, TAN EM: High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997; 40: 295-305.
20. MORRISON LJ, BEHAN WMH, BEHAN PO: Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol 1991; 83: 441-6.
21. CONTI F, MAGRINI L, PRIORI R, VALESINI G, BONINI S: Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome. Allergy 1996; 51: 124-7.
22. BENNET AL, CHAO CC, HU S et al.: Elevation of bioactive trasforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160-6.
23. CHAO CC, JANOFF EH, HU X, THOMAS K, GALLAGHER M, PETERSON PK: Altered cytokine release in peripheral mononuclear cells cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 13: 292-8.
24. VALESINI G, CONTI F, PRIORI R: Chronic fatigue syndrome: What factors trigger it off? Clin Exp Rheumatol 1994; 12: 473-6.
25. PRIORI R, CONTI F, LUAN FL, ARPINO C, VALESINI G: Chronic fatigue: A peculiar evolution of Eosinophilia Myalgia Syndrome following treatment with L-tryptophan in four Italian adolescents. Eur J Pediatr 1994; 153: 344-6.
26. BATES DW, BUCHWALD D, LEE J et al.: Clinical laboratory findings in patients with chronic fatigue syndrome. Arch Intern Med 1995; 155: 97-103.
27. FENT K, ZBINDEN G: Toxicity of interferon and interleukin. TIPS 1987; 8: 100-5.
28. BIANCHI M, SACERDOTE P, RICCIARDI-CASTAGNOLI P, MANTEGAZZA P, PANERAI AE: Central effects of tumor necrosis factor and interleukin-1τ on nociceptive thresholds and spontaneous locomotor activity. Neurosci 1992; 148: 76-80.
29. KOMAROFF AL: A 56-year-old woman with chronic fatigue syndrome. JAMA 1997; 278: 1179-85.
30. FADDA P, TORTORELLA A, FRATTA W: Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system. Neurosci Lett 1991; 129: 315-7.
31. SHER L: Exercise, wellbeing, and endogenous molecules of mood. Lancet 1996; 348:477.
32. OLSON GA, OLSON RD, KASTIN AJ: Endogenous opiates: 1995. Peptides 1996; 17: 1421-46.